NTRK2 and ovarian cancer: Given the clinical predilection of Her2-amplified tumors to develop brain metastases, we explored interactions between Her2 and TrkB because TrkB heterodimerization with EGFR could increase proliferation and migration in ovarian cancer cells [38].